IP Peru, Bioavailability of Iron From Potatoes
IPPERU
Iron Bioavailability From Iron Bio-fortified Irish Potato in Peruvian Women Between 18-25 Years of Age.
1 other identifier
interventional
36
1 country
1
Brief Summary
To combat iron deficiency in Low and Middle-Income Countries, sustainable food-based solutions have to be implemented to serve populations, not only individuals. One solution is the introduction of iron biofortified staple crops on market level. Before market level introduction, the bioavailability of iron in the new biofortified Irish Potato (IP) breed needs to be assessed. In this study the investigator compares the fractional and total iron absorption after extrinsic stable isotope labelling of the new biofortified high iron IP variety and a normal market level IP variety. The study is conducted in Peruvian women of reproductive age with marginal iron status.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 14, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 8, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 8, 2019
CompletedFirst Submitted
Initial submission to the registry
December 29, 2019
CompletedFirst Posted
Study publicly available on registry
January 2, 2020
CompletedMay 13, 2020
May 1, 2020
3 months
December 29, 2019
May 11, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Fractional iron absorption from both Irish Potato test meals
Proportion of stable isotope administered with test meals that has been incorporate into erythrocytes 14 days after completion of specific test meal feeding period
Measured 2 weeks after completion of feeding day sequence. Sequence consist of 2 times 10 feeding days.
Total iron absorption from both Irish Potato test meals
Amount of iron absorbed (mg) from the labelled test meals
Measured 2 weeks after completion of feeding day sequence. Sequence consist of 2 times 10 feeding days.
Secondary Outcomes (2)
Concentration of plasma ferritin level
screening (-1), day 1 (baseline), day 15 (before switch to other test meal type) day 26 (last feeding day) and day 40 (14 days after last test meal consumption).
Concentration of plasma CRP level
screening (-1), day 1 (baseline), day 15 (before switch to other test meal type) day 26 (last feeding day) and day 40 (14 days after last test meal consumption).
Study Arms (2)
High iron Irish potato
EXPERIMENTALMeal sequence B, IP High Fe
Regular Irish potato
ACTIVE COMPARATORMeal sequence A, OFSP control
Interventions
500 gram steamed, mashed OFSP high Fe with 0.33 mg FeSO4-58 daily for 10 days
500 gram steamed, mashed OFSP control with 0.33 mg FeSO5-57 daily for 10 days
Eligibility Criteria
You may qualify if:
- Woman aged 18-25 years old.
- Low/marginal iron status: serum ferritin (SF) ≤ 25 μg/L.
- Normal BMI for age (18.5-25.0 kg/m2).
- Weight less than 65 kg. We will give equal amounts of stable isotopes to each study participant and therefore need to set a limit on body weight in order to achieve measurable isotope enrichment in erythrocytes.
- Willing and able to commute to the meal distribution/health centre site.
- Able to understand and to sign written concept prior to trial entry.
- Informed consent signed.
- Prepared to use contraceptives for the duration of the study
You may not qualify if:
- Severe anaemia Hb \<107.2 g/L (adjusted for meters above sea level)
- Inflammation/infection (CRP \> 5 mg/100 ml).
- Relevant digestive (intestinal, gastric, hepatic or pancreatic), renal, metabolic disease, and any other problem that will interfere with the study as determined by the screening visit and by self-report from the subjects.
- Pregnant (urine test before entering the study) or breast-feeding.
- Any medication or supplement which may impact iron metabolism.
- Unwilling to discontinue vitamin and minerals supplements at least two weeks prior to the study start, as ascertained at the screening visit.
- Significant blood losses over the past 6 months (i.e. trauma, major surgery, blood donation).
- Subject who cannot be expected to comply with study procedures.
- Presence of fever (\>37.5 °C) on the first study day
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Swiss Federal Institute of Technologylead
- Genetics, Genomics and Crop Improvement Program, International Potato Center, Lima, Perucollaborator
- United States Agency for International Development (USAID)collaborator
- Quadram Institute Biosciencecollaborator
- Instituto de Investigacion Nutricional, Lima, Perucollaborator
Study Sites (1)
Instituto de Investigacion Nutricional
Lima, 1506, Peru
Related Publications (1)
Jongstra R, Mwangi MN, Burgos G, Zeder C, Low JW, Mzembe G, Liria R, Penny M, Andrade MI, Fairweather-Tait S, Zum Felde T, Campos H, Phiri KS, Zimmermann MB, Wegmuller R. Iron Absorption from Iron-Biofortified Sweetpotato Is Higher Than Regular Sweetpotato in Malawian Women while Iron Absorption from Regular and Iron-Biofortified Potatoes Is High in Peruvian Women. J Nutr. 2020 Dec 10;150(12):3094-3102. doi: 10.1093/jn/nxaa267.
PMID: 33188398DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Reyna Liria
INN
- PRINCIPAL INVESTIGATOR
Mary Penny
INN
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Participant is non-blinded based on differences in meal option A and B, meal option A --\> B or B --\> A, is assigned through investigator randomisation.
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 29, 2019
First Posted
January 2, 2020
Study Start
May 14, 2019
Primary Completion
August 8, 2019
Study Completion
August 8, 2019
Last Updated
May 13, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will not share